Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

shutter

COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches

March 24, 2020 Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma

As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
News
lung_cancer_on_chest_x-ray

AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020 Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …
News
california_state_flag

Los Angeles County and California State near lockdown after “safer-at-home” mandate is announced

March 20, 2020 Medical Communications Wuhan Coronavirus, china coronavirus, coronavirus

Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home …
News
gilead-sciences

FDA greenlights Gilead’s Epclusa in hepatitis C patients over six years old

March 20, 2020 Medical Communications, Research and Development Epclusa, Gilead, pharma

Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …
News
europe-1395916_640

Drug launches across Europe will be affected by coronavirus

March 20, 2020 Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma

The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …
News
science_nhmrc-grant-annoucement_180824_-_pic_1

New findings on influenza could help improve cancer treatments

March 20, 2020 Manufacturing and Production, Medical Communications Cancer, cancer treatments, flu, flu treatments, influenza

A new study into how the body fights influenza could help improve cancer immunotherapies. Researchers at the Fox Chase Cancer …
News
biogen_austria_238

100 coronavirus cases linked to Biogen-hosted event in Boston, State of Massachusetts confirms

March 18, 2020 Manufacturing and Production, Medical Communications, Research and Development Biogen, coronavirus, pharma

It is now known that around 100 of the known cases of the COVID-19 coronavirus can be traced to an …
News
shutterstock_273326141

$63bn Allergan/AbbVie merger review could be delayed by coronavirus

March 18, 2020 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma

The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory …
News
gill-leng-380_x_215-1

NICE promotes Professor Gillian Leng as its new Chief Executive

March 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma

NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …
News
shutterstock_206748499

New technologies and industry collaboration will help fight chronic illnesses

March 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma

Authored by Dan Boot, Head of Digital Innovation at RB Health.Around the world, populations are aging. According to the World …
Feature
anthony_mancini

Genmab announces newly-created Chief Financial Officer appointment

March 16, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genmab, pharma

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …
Appointment
5378943799_deb47ba367_b

Numerous sporting events suspended across the UK, after staff and players test positive for COVID-19

March 13, 2020 Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Sporting events across the UK have been postponed as measures are taken to halt the spread of the coronavirus. Rugby …
News
shutterstock_38078521

AstraZeneca’s cediranib combo misses main goal in platinum-sensitive relapsed ovarian cancer

March 13, 2020 Medical Communications, Research and Development AstraZeneca, cediranib, lynparza, pharma, trial failure

Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Coronavirus Wuhan, HIV, HIV/AIDS, UK Coronavirus, coronavirus

HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026